$PRLB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Proto Labs Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Proto Labs Inc. Get notifications about new insider transactions in Proto Labs Inc for free.
Page: < prev 1 2 3 4 5 6 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 09 2016 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 73.56 | 1,000 | 73,560 | 7,263 | 8.3 K to 7.3 K (-12.10 %) |
Mar 09 2016 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 1,000 | 4,270 | 8,263 | 7.3 K to 8.3 K (+13.77 %) |
Mar 03 2016 | PRLB | Proto Labs Inc | Black Archie C. | Director | Grant | A | 0.00 | 1,486 | 0 | 1,486 | 0 to 1.5 K |
Feb 19 2016 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Sell | S | 63.52 | 313 | 19,882 | 10,827 | 11.1 K to 10.8 K (-2.81 %) |
Feb 19 2016 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Sell | S | 63.94 | 410 | 26,215 | 10,627 | 11 K to 10.6 K (-3.71 %) |
Feb 10 2016 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Option Exercise | A | 26.45 | 9,455 | 250,085 | 9,455 | |
Feb 10 2016 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Grant | A | 57.88 | 4,320 | 250,042 | 11,037 | 6.7 K to 11 K (+64.31 %) |
Feb 10 2016 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Option Exercise | A | 26.45 | 9,455 | 250,085 | 9,455 | |
Feb 10 2016 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Grant | A | 57.88 | 4,320 | 250,042 | 11,140 | 6.8 K to 11.1 K (+63.34 %) |
Feb 10 2016 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Option Exercise | A | 26.45 | 9,455 | 250,085 | 9,455 | |
Feb 10 2016 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Grant | A | 57.88 | 4,320 | 250,042 | 9,203 | 4.9 K to 9.2 K (+88.47 %) |
Feb 10 2016 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Option Exercise | A | 26.45 | 9,455 | 250,085 | 9,455 | |
Feb 10 2016 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Grant | A | 57.88 | 4,320 | 250,042 | 14,124 | 9.8 K to 14.1 K (+44.06 %) |
Feb 10 2016 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 26.45 | 14,185 | 375,193 | 14,185 | |
Feb 10 2016 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 57.88 | 6,480 | 375,062 | 12,626 | 6.1 K to 12.6 K (+105.43 %) |
Feb 10 2016 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Option Exercise | A | 26.45 | 18,910 | 500,170 | 18,910 | |
Feb 10 2016 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Grant | A | 57.88 | 8,640 | 500,083 | 29,263 | 20.6 K to 29.3 K (+41.89 %) |
Apr 18 2016 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Option Exercise | M | 5.56 | 4,000 | 22,240 | 12,500 | |
Apr 18 2016 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Sell | S | 80.00 | 4,000 | 320,000 | 3,364 | 7.4 K to 3.4 K (-54.32 %) |
Apr 18 2016 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Buy | M | 5.56 | 4,000 | 22,240 | 7,364 | 3.4 K to 7.4 K (+118.91 %) |
Oct 16 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Option Exercise | M | 30.58 | 2,714 | 82,994 | 5,428 | |
Oct 16 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Buy | M | 30.58 | 2,714 | 82,994 | 9,804 | 7.1 K to 9.8 K (+38.28 %) |
Oct 05 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 67.00 | 100 | 6,700 | 7,263 | 7.4 K to 7.3 K (-1.36 %) |
Oct 05 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 65.78 | 400 | 26,313 | 7,363 | 7.8 K to 7.4 K (-5.15 %) |
Sep 01 2015 | PRLB | Proto Labs Inc | LUKIS LAWRENCE J | Director | Gift | G | 0.00 | 200,000 | 0 | 1,881,840 | 2.1 M to 1.9 M (-9.61 %) |
Aug 18 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Option Exercise | M | 47.08 | 6,468 | 304,513 | 9,702 | |
Aug 18 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Option Exercise | M | 30.58 | 5,428 | 165,988 | 8,142 | |
Aug 18 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Sell | S | 74.71 | 400 | 29,882 | 6,717 | 7.1 K to 6.7 K (-5.62 %) |
Aug 18 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Sell | S | 73.79 | 9,000 | 664,099 | 7,117 | 16.1 K to 7.1 K (-55.84 %) |
Aug 18 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Buy | M | 47.08 | 6,468 | 304,513 | 16,117 | 9.6 K to 16.1 K (+67.03 %) |
Aug 18 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Buy | M | 30.58 | 5,428 | 165,988 | 9,649 | 4.2 K to 9.6 K (+128.60 %) |
Aug 05 2015 | PRLB | Proto Labs Inc | LUKIS LAWRENCE J | Director | Sell | S | 70.50 | 500,000 | 35,250,000 | 2,081,840 | 2.6 M to 2.1 M (-19.37 %) |
Jul 28 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Option Exercise | M | 47.08 | 5,468 | 257,433 | 9,702 | |
Jul 28 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Option Exercise | M | 30.58 | 5,428 | 165,988 | 8,142 | |
Jul 28 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Option Exercise | M | 7.86 | 40,805 | 320,727 | 21,000 | |
Jul 28 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Sell | S | 79.55 | 566 | 45,025 | 7,090 | 7.7 K to 7.1 K (-7.39 %) |
Jul 28 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Sell | S | 79.10 | 25,374 | 2,007,129 | 7,656 | 33 K to 7.7 K (-76.82 %) |
Jul 28 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Sell | S | 77.87 | 4,067 | 316,691 | 33,030 | 37.1 K to 33 K (-10.96 %) |
Jul 28 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Sell | S | 76.73 | 21,694 | 1,664,505 | 37,097 | 58.8 K to 37.1 K (-36.90 %) |
Jul 28 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Buy | M | 47.08 | 5,468 | 257,433 | 58,791 | 53.3 K to 58.8 K (+10.25 %) |
Jul 28 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Buy | M | 30.58 | 5,428 | 165,988 | 53,323 | 47.9 K to 53.3 K (+11.33 %) |
Jul 28 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Buy | M | 7.86 | 40,805 | 320,727 | 47,895 | 7.1 K to 47.9 K (+575.53 %) |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Option Exercise | M | 47.08 | 3,858 | 181,635 | 12,312 | |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Option Exercise | M | 30.58 | 7,142 | 218,402 | 5,428 | |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Option Exercise | M | 7.86 | 14,000 | 110,040 | 14,000 | |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Option Exercise | M | 5.56 | 5,000 | 27,800 | 0 | |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Sell | S | 76.51 | 10,000 | 765,090 | 6,729 | 16.7 K to 6.7 K (-59.78 %) |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Sell | S | 74.55 | 10,000 | 745,481 | 16,729 | 26.7 K to 16.7 K (-37.41 %) |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Sell | S | 73.67 | 1,154 | 85,011 | 26,729 | 27.9 K to 26.7 K (-4.14 %) |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Sell | S | 73.12 | 8,846 | 646,797 | 27,883 | 36.7 K to 27.9 K (-24.08 %) |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Buy | M | 47.08 | 3,858 | 181,635 | 36,729 | 32.9 K to 36.7 K (+11.74 %) |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Buy | M | 30.58 | 7,142 | 218,402 | 32,871 | 25.7 K to 32.9 K (+27.76 %) |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Buy | M | 7.86 | 14,000 | 110,040 | 25,729 | 11.7 K to 25.7 K (+119.36 %) |
Jul 27 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Buy | M | 5.56 | 5,000 | 27,800 | 11,729 | 6.7 K to 11.7 K (+74.31 %) |
Jul 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 500 | 2,135 | 1,500 | |
Jul 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 67.50 | 500 | 33,750 | 7,763 | 8.3 K to 7.8 K (-6.05 %) |
Jul 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 500 | 2,135 | 8,263 | 7.8 K to 8.3 K (+6.44 %) |
May 22 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | A | 31.08 | 1,609 | 50,008 | 1,609 | |
May 22 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 715 | 0 | 7,763 | 7 K to 7.8 K (+10.14 %) |
May 22 2015 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Option Exercise | A | 31.08 | 1,609 | 50,008 | 1,609 | |
May 22 2015 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Sell | S | 69.75 | 399 | 27,829 | 3,364 | 3.8 K to 3.4 K (-10.60 %) |
May 22 2015 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Grant | A | 0.00 | 715 | 0 | 3,763 | 3 K to 3.8 K (+23.46 %) |
May 22 2015 | PRLB | Proto Labs Inc | KOHRS DOUGLAS W | Director | Option Exercise | A | 31.08 | 1,609 | 50,008 | 1,609 | |
May 22 2015 | PRLB | Proto Labs Inc | KOHRS DOUGLAS W | Director | Grant | A | 0.00 | 715 | 0 | 4,783 | 4.1 K to 4.8 K (+17.58 %) |
May 22 2015 | PRLB | Proto Labs Inc | Smith Brian K | Director | Option Exercise | A | 31.08 | 1,609 | 50,008 | 1,609 | |
May 22 2015 | PRLB | Proto Labs Inc | Smith Brian K | Director | Grant | A | 0.00 | 715 | 0 | 3,113 | 2.4 K to 3.1 K (+29.82 %) |
May 22 2015 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Option Exercise | A | 31.08 | 1,609 | 50,008 | 1,609 | |
May 22 2015 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Grant | A | 0.00 | 715 | 0 | 10,563 | 9.8 K to 10.6 K (+7.26 %) |
Apr 20 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Option Exercise | M | 47.08 | 1,000 | 47,080 | 15,170 | |
Apr 20 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Option Exercise | M | 7.86 | 1,195 | 9,389 | 61,805 | |
Apr 20 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Buy | M | 47.08 | 1,000 | 47,080 | 7,090 | 6.1 K to 7.1 K (+16.42 %) |
Apr 20 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Sell | S | 79.00 | 1,195 | 94,405 | 6,090 | 7.3 K to 6.1 K (-16.40 %) |
Apr 20 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP and Te ... | Buy | M | 7.86 | 1,195 | 9,389 | 7,285 | 6.1 K to 7.3 K (+19.62 %) |
Apr 17 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Option Exercise | M | 5.56 | 2,000 | 11,120 | 5,000 | |
Apr 17 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Sell | S | 77.80 | 2,000 | 155,600 | 6,729 | 8.7 K to 6.7 K (-22.91 %) |
Apr 17 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Buy | M | 5.56 | 2,000 | 11,120 | 8,729 | 6.7 K to 8.7 K (+29.72 %) |
Apr 14 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Option Exercise | M | 7.86 | 9,000 | 70,740 | 21,000 | |
Apr 14 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Option Exercise | M | 7.86 | 12,000 | 94,320 | 30,000 | |
Apr 14 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Sell | S | 75.01 | 9,000 | 675,062 | 4,221 | 13.2 K to 4.2 K (-68.07 %) |
Apr 14 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Buy | M | 7.86 | 9,000 | 70,740 | 13,221 | 4.2 K to 13.2 K (+213.22 %) |
Apr 14 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Sell | S | 75.12 | 12,000 | 901,390 | 4,221 | 16.2 K to 4.2 K (-73.98 %) |
Apr 14 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Buy | M | 7.86 | 12,000 | 94,320 | 16,221 | 4.2 K to 16.2 K (+284.29 %) |
Apr 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 500 | 2,135 | 2,000 | |
Apr 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 69.76 | 500 | 34,878 | 7,048 | 7.5 K to 7 K (-6.62 %) |
Apr 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 500 | 2,135 | 7,548 | 7 K to 7.5 K (+7.09 %) |
Mar 24 2015 | PRLB | Proto Labs Inc | Smith Brian K | Director | Buy | P | 63.09 | 1,600 | 100,944 | 2,398 | 798 to 2.4 K (+200.50 %) |
Mar 20 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 500 | 2,135 | 2,500 | |
Mar 20 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 69.40 | 500 | 34,700 | 7,048 | 7.5 K to 7 K (-6.62 %) |
Mar 20 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 500 | 2,135 | 7,548 | 7 K to 7.5 K (+7.09 %) |
Feb 26 2015 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Sell | S | 82.58 | 155 | 12,800 | 4,685 | 4.8 K to 4.7 K (-3.20 %) |
Feb 19 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | Vice President Glob ... | Sell | S | 73.65 | 151 | 11,121 | 6,729 | 6.9 K to 6.7 K (-2.19 %) |
Feb 17 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Sell | S | 71.67 | 364 | 26,088 | 4,221 | 4.6 K to 4.2 K (-7.94 %) |
Feb 11 2015 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Option Exercise | A | 67.15 | 17,990 | 1,208,029 | 17,990 | |
Feb 11 2015 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Grant | A | 0.00 | 4,695 | 0 | 20,623 | 15.9 K to 20.6 K (+29.48 %) |
Feb 11 2015 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 67.15 | 9,995 | 671,164 | 9,995 | |
Feb 11 2015 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 0.00 | 2,610 | 0 | 5,790 | 3.2 K to 5.8 K (+82.08 %) |
Feb 11 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP of Tec ... | Option Exercise | A | 67.15 | 9,995 | 671,164 | 9,995 | |
Feb 11 2015 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Executive VP of Tec ... | Grant | A | 0.00 | 2,610 | 0 | 6,090 | 3.5 K to 6.1 K (+75.00 %) |
Feb 11 2015 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Option Exercise | A | 67.15 | 9,995 | 671,164 | 9,995 | |
Feb 11 2015 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Grant | A | 0.00 | 2,610 | 0 | 4,840 | 2.2 K to 4.8 K (+117.04 %) |
Feb 11 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | VP of Sales & Custo ... | Option Exercise | A | 67.15 | 9,995 | 671,164 | 9,995 | |
Feb 11 2015 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | VP of Sales & Custo ... | Grant | A | 0.00 | 2,610 | 0 | 6,880 | 4.3 K to 6.9 K (+61.12 %) |
Feb 11 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Option Exercise | A | 67.15 | 4,745 | 318,627 | 4,745 | |
Feb 11 2015 | PRLB | Proto Labs Inc | Tumelty John B. | VP/GM & Managing Di ... | Grant | A | 0.00 | 1,240 | 0 | 4,585 | 3.3 K to 4.6 K (+37.07 %) |
Dec 03 2014 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 62.90 | 6,520 | 410,108 | 6,520 | |
Dec 03 2014 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 0.00 | 3,180 | 0 | 3,180 | 0 to 3.2 K |
Oct 07 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 30.58 | 1,000 | 30,580 | 0 | |
Oct 07 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 70.20 | 1,000 | 70,205 | 7,048 | 8 K to 7 K (-12.43 %) |
Oct 07 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 30.58 | 1,000 | 30,580 | 8,048 | 7 K to 8 K (+14.19 %) |
Oct 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 2,000 | 8,540 | 3,000 | |
Oct 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 68.84 | 800 | 55,070 | 7,048 | 7.8 K to 7 K (-10.19 %) |
Oct 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 68.03 | 1,200 | 81,630 | 7,848 | 9 K to 7.8 K (-13.26 %) |
Oct 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 2,000 | 8,540 | 9,048 | 7 K to 9 K (+28.38 %) |
Aug 01 2014 | PRLB | Proto Labs Inc | JUDD JOHN R | CFO & Principal Acc ... | Option Exercise | M | 20.07 | 75,000 | 1,505,250 | 0 | |
Aug 01 2014 | PRLB | Proto Labs Inc | JUDD JOHN R | CFO & Principal Acc ... | Sell | S | 81.06 | 45,674 | 3,702,152 | 2,230 | 47.9 K to 2.2 K (-95.34 %) |
Aug 01 2014 | PRLB | Proto Labs Inc | JUDD JOHN R | CFO & Principal Acc ... | Sell | S | 80.51 | 29,326 | 2,361,083 | 47,904 | 77.2 K to 47.9 K (-37.97 %) |
Aug 01 2014 | PRLB | Proto Labs Inc | JUDD JOHN R | CFO & Principal Acc ... | Buy | M | 20.07 | 75,000 | 1,505,250 | 77,230 | 2.2 K to 77.2 K (+3,363.23 %) |
Jul 01 2014 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | VP of Sales & Custo ... | Option Exercise | M | 7.86 | 14,000 | 110,040 | 28,000 | |
Jul 01 2014 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | VP of Sales & Custo ... | Sell | S | 88.98 | 14,000 | 1,245,765 | 4,270 | 18.3 K to 4.3 K (-76.63 %) |
Jul 01 2014 | PRLB | Proto Labs Inc | Schneider Jacqueline D. | VP of Sales & Custo ... | Buy | M | 7.86 | 14,000 | 110,040 | 18,270 | 4.3 K to 18.3 K (+327.87 %) |
Jul 01 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 30.58 | 1,000 | 30,580 | 1,000 | |
Jul 01 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 2,000 | 8,540 | 5,000 | |
Jul 01 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 82.91 | 3,000 | 248,720 | 7,048 | 10 K to 7 K (-29.86 %) |
Jul 01 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 30.58 | 1,000 | 30,580 | 10,048 | 9 K to 10 K (+11.05 %) |
Jul 01 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 2,000 | 8,540 | 9,048 | 7 K to 9 K (+28.38 %) |
Jun 30 2014 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Option Exercise | M | 5.56 | 1,000 | 5,560 | 16,500 | |
Jun 30 2014 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Sell | S | 80.42 | 1,000 | 80,420 | 3,048 | 4 K to 3 K (-24.70 %) |
Jun 30 2014 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Buy | M | 5.56 | 1,000 | 5,560 | 4,048 | 3 K to 4 K (+32.81 %) |
May 22 2014 | PRLB | Proto Labs Inc | Smith Brian K | Director | Option Exercise | A | 62.68 | 1,731 | 108,499 | 1,731 | |
May 22 2014 | PRLB | Proto Labs Inc | Smith Brian K | Director | Grant | A | 0.00 | 798 | 0 | 798 | 0 to 798 |
May 22 2014 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Option Exercise | A | 62.68 | 1,731 | 108,499 | 1,731 | |
May 22 2014 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Grant | A | 0.00 | 798 | 0 | 9,848 | 9.1 K to 9.8 K (+8.82 %) |
May 22 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | A | 62.68 | 1,731 | 108,499 | 1,731 | |
May 22 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 798 | 0 | 7,048 | 6.3 K to 7 K (+12.77 %) |
May 22 2014 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Option Exercise | A | 62.68 | 1,731 | 108,499 | 1,731 | |
May 22 2014 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Grant | A | 0.00 | 798 | 0 | 3,048 | 2.3 K to 3 K (+35.47 %) |
May 22 2014 | PRLB | Proto Labs Inc | KOHRS DOUGLAS W | Director | Option Exercise | A | 62.68 | 1,731 | 108,499 | 1,731 | |
May 22 2014 | PRLB | Proto Labs Inc | KOHRS DOUGLAS W | Director | Grant | A | 0.00 | 798 | 0 | 4,068 | 3.3 K to 4.1 K (+24.40 %) |
May 22 2014 | PRLB | Proto Labs Inc | Cleveland Bradley A. | CEO | Option Exercise | A | 62.68 | 1,731 | 108,499 | 1,731 | |
May 22 2014 | PRLB | Proto Labs Inc | Cleveland Bradley A. | CEO | Grant | A | 0.00 | 798 | 0 | 798 | 0 to 798 |
Apr 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 30.58 | 1,000 | 30,580 | 2,000 | |
Apr 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 2,000 | 8,540 | 7,000 | |
Apr 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 30.58 | 1,762 | 53,882 | 3,000 | |
Apr 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 2,000 | 8,540 | 9,000 | |
Apr 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 70.18 | 1,000 | 70,180 | 6,250 | 7.3 K to 6.3 K (-13.79 %) |
Apr 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 30.58 | 1,000 | 30,580 | 7,250 | 6.3 K to 7.3 K (+16.00 %) |
Apr 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 67.98 | 2,000 | 135,960 | 6,250 | 8.3 K to 6.3 K (-24.24 %) |
Apr 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 2,000 | 8,540 | 8,250 | 6.3 K to 8.3 K (+32.00 %) |
Apr 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 73.61 | 452 | 33,271 | 6,250 | 6.7 K to 6.3 K (-6.74 %) |
Apr 02 2014 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 73.05 | 3,310 | 241,783 | 6,702 | 10 K to 6.7 K (-33.06 %) |